Procter & Gamble Health Ltd

Company Profile

Procter & Gamble Health Ltd had its IPO on under the ticker symbol PGHL.

The company operates in the Other sector and Other industry. Procter & Gamble Health Ltd has a staff strength of 0 employees.

Stock update

Shares of Procter & Gamble Health Ltd opened at ₹5119.95 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹5019.8 - ₹5144, and closed at ₹5098.

This is a +0.43% increase from the previous day's closing price.

A total volume of 832 shares were traded at the close of the day’s session.

In the last one week, shares of Procter & Gamble Health Ltd have increased by +1.87%.

Procter & Gamble Health Ltd's Key Ratios

Procter & Gamble Health Ltd has a market cap of ₹66.08 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Procter & Gamble Health Ltd’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Procter & Gamble Health Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Procter & Gamble Health Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q4, Procter & Gamble Health Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Procter & Gamble Health Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Procter & Gamble Health Ltd’s profitability.

Procter & Gamble Health Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Procter & Gamble Health Ltd stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 47.89%.

Balance sheet and cash flow metrics

Total Assets

₹9.91 billion

Total Liabilities

₹2.25 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

47.89%

Procter & Gamble Health Ltd ended 2024 with ₹9.91 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹9.91 billion while shareholder equity stood at ₹7.33 billion.

Procter & Gamble Health Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹2.25 billion in other current liabilities, 165994000.00 in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹2.78 billion and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Procter & Gamble Health Ltd’s total current assets stands at ₹7.52 billion while long-term investments were ₹86.14 million and short-term investments were ₹845.23 million. Its net receivables were ₹1.23 billion compared to accounts payable of ₹832.83 million and inventory worth ₹1.58 billion.

In 2024, Procter & Gamble Health Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Procter & Gamble Health Ltd paid ₹0.48 in dividends in 2024.

Other key metrics

Current Trading Price

₹5098

52-Week High

₹5240

52-Week Low

₹3848.8859

Analyst Target Price

₹

Procter & Gamble Health Ltd stock is currently trading at ₹5098 per share. It touched a 52-week high of ₹5240 and a 52-week low of ₹5240. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹5166.93 and 200-day moving average was ₹4747.76 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.